Skip to content
drillr.ai
Sign up

688399.SH

硕世生物

SSE · Healthcare · Biotechnology · CN

CNY 27.85
−2.76%
Ask drillr

  • Aug 27, 2026, 11:33 UTC

    Suzhou Sursen Biopharmaceutical Co., Ltd. announced its 2026 first-half results: net profit attributable to shareholders was 19.5646 million yuan, up 390.02% year-on-year, with revenue of 147 million yuan, down 16.03%.

    Source: